Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospital

scientific article

Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospital is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/CIRCHEARTFAILURE.113.000284
P698PubMed publication ID24281134

P50authorPiotr PonikowskiQ22114836
Gad CotterQ37623977
Beth A. DavisonQ39274037
Marco MetraQ39274051
John ClelandQ44931654
Karen ChiswellQ64683299
Christopher M O'ConnorQ64689171
Susanna R StevensQ64856812
Michael M GivertzQ90393574
John R TeerlinkQ90422543
Adriaan A VoorsQ91537232
Barry M. MassieQ114321736
George A. MansoorQ114429076
P2093author name stringMona Fiuzat
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectheart failureQ181754
placeboQ269829
acute decompensated heart failureQ4677930
P304page(s)76-87
P577publication date2013-11-26
P1433published inCirculation: Heart FailureQ2865806
P1476titlePredictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospital
P478volume7

Reverse relations

cites work (P2860)
Q57422643Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial
Q30234708Addressing the Heterogeneity of Heart Failure in Future Randomized Trials.
Q38262814Adenosine, type 1 receptors: role in proximal tubule Na+ reabsorption
Q26800965Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review
Q64945828Association of admission vs. nadir serum albumin concentration with short-term treatment outcomes in patients with acute heart failure.
Q88160619Associations between volume status and circulating microRNAs in acute heart failure
Q38626779Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure
Q92666278Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score
Q91662964Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission
Q88035084Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF
Q38960401Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial
Q47279019Critical Appraisal of Multivariable Prognostic Scores in Heart Failure: Development, Validation and Clinical Utility
Q38201299Decision-making under uncertainty in advanced heart failure
Q36932609Depression and Multiple Rehospitalizations in Patients With Heart Failure
Q40313672Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure
Q35810391Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Q39338234Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review
Q44129824Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial
Q38851058Echocardiographic predictors of outcome in acute heart failure patients in sub-Saharan Africa: insights from THESUS-HF
Q38705811Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure
Q94487073Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study
Q104258992Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis
Q46465745In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry
Q58554416Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey
Q51226890Non classical Monocytes Levels, Increased by Subcutaneous Fat-Secretome, Are Associated with Less Rehospitalization after Heart Failure Admission.
Q41074638Optimizing clinical use of biomarkers in high-risk acute heart failure patients
Q38560109Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality
Q89903377Pharmacological interventions for heart failure in people with chronic kidney disease
Q40126626Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure
Q40311889Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure
Q41174254Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome
Q37624195Precipitating Factors for Acute Heart Failure Hospitalization and Long-Term Survival
Q58788721Prediction of readmissions and mortality in patients with heart failure: lessons from the IMPEDANCE-HF extended trial
Q47580229Provider Connectedness to Other Providers Reduces Risk of Readmission After Hospitalization for Heart Failure
Q59637210Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF)
Q99413029Suppression Tumorigenicity 2 (ST2) Turbidimetric Immunoassay Compared to Enzyme-Linked Immunosorbent Assay in Predicting Survival in Heart Failure Patients with Reduced Ejection Fraction
Q64279311The role of intestinal microbiota in cardiovascular disease
Q88915069Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan
Q26771479What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?

Search more.